6 Surprising Symptoms of Menopause

Six Surprising Symptoms of Menopause – And How to Support.

As women approach and experience menopause, they may be familiar with some of the classic symptoms like hot flashes and night sweats. However, there are lesser-known symptoms that can be just as impactful. Nurse Practitioner Barb Dehn has outlined six surprising symptoms associated with menopause and ways to give your body additional support during this time.

1. Joint Pain

More than 50% of women going through menopause experience joint pain1, which can manifest as a dull ache, loss of movement, or even weakness. This is due to the decline in estrogen levels, as estrogen receptors are found in joints(2,3,4). Without adequate estrogen, stiffness and discomfort can increase. Common management options may include non-steroidal anti-inflammatory drugs to address discomfort, as well as Vitamins D with K2 to support bone health(5).

2. Hair Changes

Another symptom that can catch many women off guard is changes to their hair. Around 50% of postmenopausal women experience female pattern hair loss(6). Hormonal changes, underlying health conditions, use of certain medications, stress, and nutritional deficiencies may all play a role(7). Hair may become thinner, shorter, or sparser around the temples and crown. In some cases, a foam or vasodilator solution may be recommended by a healthcare professional. Nutritional recommendations may include B-complex vitamins, Vitamin D, as well as increased dietary protein(8,9,10,11,12).

3. Anxiety

Menopause can also affect mental health, with anywhere from 15-50% of women experiencing anxiety(13). This can manifest as heart palpitations, ruminating thoughts, and even avoidance behaviors or phobias. Alongside hormonal changes, factors like lifestyle, body image, and relationships contribute to these feelings(2). Improving sleep patterns may improve symptoms associated with anxiety. Common management recommendations may include Cognitive Behavioral Therapy (CBT), SSRIs, and/or SNRIs(14,15).

4. Acne

While acne may seem like a concern from adolescence, approximately 15% of women aged 50 or older experience acne during menopause(16). This is primarily due to a hormonal imbalance between declining estrogen and androgens(16). Skin blemishes, including blackheads and whiteheads, may be treated by a healthcare professional with a specialized facial washes and/or a retinoid cream(17,18).

5. Dryness

Menopause also brings a range of dryness issues; around 33% experience dry mouth(19), 50% experience skin problems(20), and 70% experience dry eyes(21). This is due to declining estrogen and progesterone levels(22-24). Omega 3 fatty acids can support eye health, vaginal moisturizers with hyaluronic acid can help with skin dryness, and saliva substitutes can alleviate oral dryness(25,26).

6. Decreased Libido

Finally, more than 33% of women in menopause report experiencing a reduced libido(27). Lower estrogen levels can make sexual arousal more difficult and decrease overall interest(27). Treatment options may include prescription medications, as well as vaginal moisturizers and local estrogen treatments to alleviate discomfort(28,29,30).

Menopause is a unique journey for each woman, but being aware of these symptoms can help you better understand and manage them. If you experience any of these symptoms, it is recommended to reach out to a healthcare provider for personalized support.

References

1. Mahajan, A., Sharma, S., & Tandon, V. R. (2023). Joint pains in perimenopause/ menopause. JK Science, 25(2), 63-65.
2. Deeks, A. A. (2003). Psychological aspects of menopause management. Best Practice & Research Clinical Endocrinology & Metabolism, 17(1), 17-31. https://doi.org/10.1016/S1521-690X(02)00077-5
3. Brayer, T. (n.d.). Menopause with Joint and Muscle Pain. Sutter Health. https://www.sutterhealth.org/ask-an-expert/answers/menopause-with-joint-muscle-pain
4. Chidi-Ogbolu N, Baar K. Effect of Estrogen on Musculoskeletal Performance and Injury Risk. Front Physiol. 2019 Jan 15;9:1834. doi: 10.3389/fphys.2018.01834. PMID: 30697162; PMCID: PMC6341375.
5. Wright VJ, Schwartzman JD, Itinoche R, Wittstein J. The musculoskeletal syndrome of menopause. Climacteric. 2024 Oct;27(5):466-472. doi: 10.1080/13697137.2024.2380363. Epub 2024 Jul 30. PMID: 39077777. 2. Watt FE. Musculoskeletal pain and menopause. Post Reprod Health. 2018 Mar;24(1):34-43. doi: 10.1177/2053369118757537. Epub 2018 Feb 7. PMID: 29412042.
6. Chaikittisilpa, S., Rattanasirisin, N., Panchaprateep, R., Orprayoon, N., Phutrakul, P., Suwan, A., & Jaisamrarn, U. (2022). Prevalence of female pattern hair loss in postmenopausal women: A cross-sectional study. Menopause (New York, N.Y.), 29(4), 415–420. https://doi.org/10.1097/GME.0000000000001927
7. Rinaldi, F., Trink, A., Mondadori, G., Giuliani, G., & Pinto, D. (2023). The menopausal transition: Is the hair follicle "going through menopause"? Biomedicines, 11(11), 3041. https://doi.org/10.3390/biomedicines11113041
8. Kim K.H., Kwon S.H., Lee Y.J., Sim W.Y., Lew B.L. Efficacy of finasteride in female pattern hair loss: a meta-analysis. Ann Dermatol. 2021;33:304–307.
9. Müller Ramos P, Melo DF, Radwanski H, de Almeida RFC, Miot HA. Female-pattern hair loss: therapeutic update. An Bras Dermatol. 2023 Jul-Aug;98(4):506-519. doi: 10.1016/j.abd.2022.09.006. Epub 2023 Mar 30. PMID: 37003900; PMCID: PMC10334345.
10. Kamp E, Ashraf M, Musbahi E, DeGiovanni C. Menopause, skin and common dermatoses. Part 1: hair disorders. Clin Exp Dermatol. 2022 Dec;47(12):2110-2116. doi: 10.1111/ced.15327. Epub 2022 Oct 28. PMID: 35796569; PMCID: PMC10092469.
11. Iamsumang W, Leerunyakul K, Suchonwanit P. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date. Drug Des Devel Ther. 2020 Mar 2;14:951-959. doi: 10.2147/DDDT.S240615. PMID: 32184564; PMCID: PMC7060023.
12. Trüeb RM; Swiss Trichology Study Group. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology. 2004;209(3):202-7. doi: 10.1159/000079890. PMID: 15459533.
13. Huang, S., Wang, Z., Zheng, D., & Liu, L. (2023). Anxiety disorder in menopausal women and the intervention efficacy of mindfulness-based stress reduction. American Journal of Translational Research, 15(3), 2016–2024.
14. The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023 Jun 1;30(6):573-590. doi: 10.1097/GME.0000000000002200. PMID: 37252752.
15. Stute P, Lozza-Fiacco S. Strategies to cope with stress and anxiety during the menopausal transition. Maturitas. 2022 Dec;166:1-13. doi: 10.1016/j.maturitas.2022.07.015. Epub 2022 Aug 3. PMID: 35964446. https://doi.org/10.1016/S1521-690X(02)00077-5
16. Khunger, N., & Mehrotra, K. (2019). Menopausal Acne – Challenges And Solutions. International Journal of Women’s Health, 11, 555–567. https://doi.org/10.2147/IJWH.S174292
17. Dias da Rocha MA, Saint Aroman M, Mengeaud V, Carballido F, Doat G, Coutinho A, Bagatin E. Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence. Int J Womens Health. 2024 Apr 18;16:663-678. doi: 10.2147/IJWH.S431523. PMID: 38650835; PMCID: PMC11034510.
18. Khunger N, Mehrotra K. Menopausal Acne - Challenges And Solutions. Int J Womens Health. 2019 Oct 29;11:555-567. doi: 10.2147/IJWH.S174292. PMID: 31754313; PMCID: PMC6825478.
19. https://www1.deltadentalins.com/content/dam/ddins/en/pdf/wellness/oral-health-and-menopause-report.pdf
20. Bravo B, Penedo L, Carvalho R, Dal Vesco C, Calomeni M, Gapanowicz D, Kemen E, Paes R, Renke G. Dermatological Changes during Menopause and HRT: What to Expect? Cosmetics. 2024; 11(1):9. https://doi.org/10.3390/cosmetics11010009
21. Garcia-Alfaro, P., Garcia, S., Rodriguez, I., & Vergés, C. (2021). Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women. Climacteric : the journal of the International Menopause Society, 24(3), 261–266. https://doi.org/10.1080/13697137.2020.1849087
22. Peck T, Olsakovsky L, Aggarwal S. Dry Eye Syndrome in Menopause and Perimenopausal Age Group. J Midlife Health. 2017 Apr-Jun;8(2):51-54. doi: 10.4103/jmh.JMH_41_17. PMID: 28706404; PMCID: PMC5496280.
23. Nair PA. Dermatosis associated with menopause. J Midlife Health. 2014 Oct;5(4):168-75. doi: 10.4103/0976-7800.145152. PMID: 25540566; PMCID: PMC4264279.
24. Mirzaii-Dizgah, I., Agha-Hosseini, F. Stimulated and unstimulated saliva progesterone in menopausal women with oral dryness feeling. Clin Oral Invest 15, 859–862 (2011). https://doi.org/10.1007/s00784-010-0449-z
25. Bhargava R, Pandey K, Ranjan S, Mehta B, Malik A. Omega-3 fatty acids supplements for dry eye - Are they effective or ineffective? Indian J Ophthalmol. 2023 Apr;71(4):1619-1625. doi: 10.4103/IJO.IJO_2789_22. PMID: 37026312; PMCID: PMC10276704.
26. Buzzaccarini G, Marin L, Noventa M, Vitagliano A, Riva A, Dessole F, Capobianco G, Bordin L, Andrisani A, Ambrosini G. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric. 2021 Dec;24(6):560-571. doi: 10.1080/13697137.2021.1898580. Epub 2021 Mar 24. PMID: 33759670.
27. How Sex Changes After Menopause. (n.d.). Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/wellness-and-prevention/how-sex-changes-after-menopause
28. Potter N, Panay N. Vaginal lubricants and moisturizers: a review into use, efficacy, and safety. Climacteric. 2021 Feb;24(1):19-24. doi: 10.1080/13697137.2020.1820478. Epub 2020 Sep 29. PMID: 32990054.
29. The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020 Sep;27(9):976-992. doi: 10.1097/GME.0000000000001609. PMID: 32852449.
30. Pachano Pesantez GS, Clayton AH. Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options. Focus (Am Psychiatr Publ). 2021 Jan;19(1):39-45. doi: 10.1176/appi.focus.20200039. Epub 2021 Jan 25. PMID: 34483765; PMCID: PMC8412154.